Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?
Cannistra
Stephen A
SA
D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010166:Palliative Care; D010984:Platinum / Q000627:therapeutic use
D010984:Platinum